Opposition to vaccination a transatlantic discussion /

Viečča ollesdeavstta
Series

The development of therapeutic antibodies against oncogenic antigens

Viečča ollesdeavstta
Series

Elective caesarean sections from an evolutionary perspective

Viečča ollesdeavstta
Series

Elite controllers of HIV from discovery to future therapies /

Viečča ollesdeavstta
Series

Precision cancer medicine development and future /

Viečča ollesdeavstta
Series

Combating the HIV epidemic

Viečča ollesdeavstta

MassBank development and future

Viečča ollesdeavstta
Series

Addressing required changes in the UK health system for the health and wellbeing for individuals with learning (intellectual) disabilities

Viečča ollesdeavstta

Pediatric cancer testing

Viečča ollesdeavstta
Series

The COVID-19 coronavirus outbreak a current view /

Viečča ollesdeavstta
Series

The COVID-19 outbreak an update on the SARS-CoV-2 virus /

Viečča ollesdeavstta
Series

SARS-CoV-2 vaccine development

Viečča ollesdeavstta
Series

The immune system response to the SARS-COV-2 virus

Viečča ollesdeavstta
Series

The paediatric response to the SARS-COV-2 virus and what we can learn from it

Viečča ollesdeavstta
Series

The current understanding of the biology of the SARS-COV-2 virus

Viečča ollesdeavstta
Series

The COVID-19 coronavirus outbreak March 2020 update /

Viečča ollesdeavstta
Series

SARS-COV-2 vaccine current biological targets and considerations /

Viečča ollesdeavstta
Series

SARS-COV-2 what we need to know and possible future therapies /

Viečča ollesdeavstta
Series

SARS-COV-2 vaccine development where are we now? /

Viečča ollesdeavstta
Series

COVID-19 epidemiology and potential treatments follow up interview /

Viečča ollesdeavstta
Series